[go: up one dir, main page]

WO2008038140A3 - Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof - Google Patents

Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof Download PDF

Info

Publication number
WO2008038140A3
WO2008038140A3 PCT/IB2007/003463 IB2007003463W WO2008038140A3 WO 2008038140 A3 WO2008038140 A3 WO 2008038140A3 IB 2007003463 W IB2007003463 W IB 2007003463W WO 2008038140 A3 WO2008038140 A3 WO 2008038140A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypropylene glycol
alkyl ether
pharmaceutical compositions
glycol alkyl
foamable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2007/003463
Other languages
French (fr)
Other versions
WO2008038140A2 (en
Inventor
Doron Freidman
Dov Tamarkin
Naomi Feiman
David Schuz
Tal Berman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Foamix Ltd
Original Assignee
Foamix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/481,596 external-priority patent/US8119150B2/en
Priority claimed from US11/488,989 external-priority patent/US10117812B2/en
Priority claimed from US11/717,897 external-priority patent/US8119109B2/en
Application filed by Foamix Ltd filed Critical Foamix Ltd
Priority to EP07848880A priority Critical patent/EP2029106A2/en
Publication of WO2008038140A2 publication Critical patent/WO2008038140A2/en
Publication of WO2008038140A3 publication Critical patent/WO2008038140A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N53/00—Biocides, pest repellants or attractants, or plant growth regulators containing cyclopropane carboxylic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/16—Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention teaches a foamable pharmaceutical carrier comprising polypropylene glycol (PPG) alkyl ether, a surface-active agent water and a liquefied hydrocarbon gas propellant; and pharmaceutical compositions thereof. The present invention further teaches a foamable pharmaceutical carrier comprising polypropylene glycol (PPG) alkyl ether, a surface-active agent, and a liquefied hydrocarbon gas propellant; and pharmaceutical compositions thereof.
PCT/IB2007/003463 2006-06-07 2007-06-07 Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof Ceased WO2008038140A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07848880A EP2029106A2 (en) 2006-06-07 2007-06-07 Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US81162706P 2006-06-07 2006-06-07
US60/811,627 2006-06-07
US11/481,596 US8119150B2 (en) 2002-10-25 2006-07-06 Non-flammable insecticide composition and uses thereof
US11/482,596 2006-07-07
US11/488,989 2006-07-19
US11/488,989 US10117812B2 (en) 2002-10-25 2006-07-19 Foamable composition combining a polar solvent and a hydrophobic carrier
US11/717,897 2007-03-13
US11/717,897 US8119109B2 (en) 2002-10-25 2007-03-13 Foamable compositions, kits and methods for hyperhidrosis

Publications (2)

Publication Number Publication Date
WO2008038140A2 WO2008038140A2 (en) 2008-04-03
WO2008038140A3 true WO2008038140A3 (en) 2008-09-04

Family

ID=39230597

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/003463 Ceased WO2008038140A2 (en) 2006-06-07 2007-06-07 Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof

Country Status (2)

Country Link
EP (1) EP2029106A2 (en)
WO (1) WO2008038140A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8946276B2 (en) 2011-06-28 2015-02-03 Watson Laboratories, Inc. High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
PL1871433T3 (en) 2005-03-24 2009-09-30 Nolabs Ab Cosmetic treatment with nitric oxide, device for performing said treatment and manufacturing method therefor
ES2447301T3 (en) 2005-06-01 2014-03-11 Glaxosmithkline Intellectual Property Development Limited Vitamin formulation
PT2344198T (en) 2008-09-27 2020-12-04 Jina Pharmaceuticals Inc Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof
US9387160B2 (en) 2008-12-22 2016-07-12 Johnson & Johnson Consumer Holdings France Composition and method of treating skin conditions
PL2210588T3 (en) 2008-12-23 2011-09-30 Intendis Gmbh Foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin
EP2421496A4 (en) * 2009-04-22 2014-01-15 Agency Science Tech & Res EMULSIONS FOR TRANSDERMAL ADMINISTRATION
CA3062005C (en) 2009-08-21 2022-02-15 Novan, Inc. Topical gels comprising nitric oxide-releasing polysiloxane macromolecules and uses thereof
EP2467173B8 (en) 2009-08-21 2019-06-19 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
WO2011112875A2 (en) 2010-03-10 2011-09-15 Nuvo Research Inc. Foamable formulation
BR112014000178A2 (en) 2011-07-05 2017-02-07 Novan Inc topical compositions
WO2013006613A1 (en) 2011-07-05 2013-01-10 Novan, Inc. Methods of manufacturing topical compositions and apparatus for same
CA2865526C (en) 2012-03-14 2020-06-23 Novan, Inc. Nitric oxide releasing pharmaceutical compositions
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
FR3004641B1 (en) * 2013-04-17 2016-01-15 Oreal COSMETIC COMPOSITION COMPRISING A CUCURBIC ACID COMPOUND AND OXYALKYLENE POLY (POLY) OIL
WO2015021382A2 (en) 2013-08-08 2015-02-12 Novan, Inc. Topical compositions and methods of using the same
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
AU2015287674B2 (en) 2014-07-11 2019-11-21 Ligand Pharmaceuticals Incorporated Topical antiviral compositions and methods of using the same
US10925689B2 (en) 2014-07-14 2021-02-23 Novan, Inc. Nitric oxide releasing nail coating compositions, nitric oxide releasing nail coatings, and methods of using the same
CN105813617B (en) 2014-08-08 2021-05-28 诺万公司 Topical compositions and methods of using the same
WO2017019535A2 (en) 2015-07-24 2017-02-02 Kimberly-Clark Worldwide, Inc. Methods for lymphatic delivery of active agents
US10849864B2 (en) 2015-07-28 2020-12-01 Novan, Inc. Combinations and methods for the treatment and/or prevention of fungal infections
WO2017023622A1 (en) * 2015-08-06 2017-02-09 The Dial Corporation Antiperspirant compositions with masking agents and methods for producing the same
DE102015221568A1 (en) 2015-11-04 2017-05-04 Beiersdorf Ag Cosmetic foam of an emulsion containing glycerol and alcohol
WO2017151905A1 (en) 2016-03-02 2017-09-08 Novan, Inc. Compositions for treating inflammation and methods of treating the same
US11166980B2 (en) 2016-04-13 2021-11-09 Novan, Inc. Compositions, systems, kits, and methods for treating an infection
CN109715251B (en) * 2016-09-19 2024-06-21 宝洁公司 Foam compositions, aerosol products and methods of use thereof for improving sensory benefits to skin
EP3743047A1 (en) * 2018-01-26 2020-12-02 The Procter & Gamble Company Methods and compositions for reducing the feeling of vaginal dryness
EP3743044A1 (en) * 2018-01-26 2020-12-02 The Procter & Gamble Company Methods and compositions for reducing the feeling of vaginal dryness
JP2021515807A (en) 2018-03-01 2021-06-24 ノーバン，インク． Nitric oxide-releasing suppositories and methods of their use
GB2574022A (en) * 2018-05-22 2019-11-27 Thornton & Ross Ltd A pediculicidal shampoo
GB201813876D0 (en) 2018-08-24 2018-10-10 Antibiotx As Treatment
WO2020089467A1 (en) 2018-11-02 2020-05-07 UNION therapeutics A/S Dosage regimen
EP3873481A1 (en) 2018-11-02 2021-09-08 UNION therapeutics A/S Halogenated salicylanilides for treating the symptoms of dermatitis
DE102018009781A1 (en) * 2018-12-13 2020-06-18 Valeopharm GmbH Foamable aqueous preparations based on natural biopolymers with flexible gas (- especially oxygen gas) storage cell distribution
US11590073B2 (en) 2020-06-09 2023-02-28 The Procter & Gamble Company Methods and compositions for reducing the feeling of vaginal dryness
USD998474S1 (en) 2020-11-25 2023-09-12 The Procter & Gamble Company Aerosol dispenser
USD1015881S1 (en) 2021-05-03 2024-02-27 The Procter & Gamble Company Aerosol foam dispenser
WO2022235542A1 (en) * 2021-05-03 2022-11-10 The Procter & Gamble Company Foam compositions
WO2022235600A1 (en) 2021-05-03 2022-11-10 The Procter & Gamble Company Aerosol foam dispenser

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5429815A (en) * 1994-04-11 1995-07-04 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Stable single-phase self-foaming cleanser
US5783202A (en) * 1995-03-14 1998-07-21 Soltec Research Pty. Ltd. Pediculicidal mousse composition for killing head lice
EP1287813A1 (en) * 2001-08-28 2003-03-05 Coty Inc. Antiperspirant deodorant emulsion
US20030053961A1 (en) * 2001-07-13 2003-03-20 Eccard Wayne Ellis Mousse forming compositions comprising quaternary ammonium agents
EP1428521A2 (en) * 2002-12-13 2004-06-16 Unilever Plc Antiperspirant or deodorant composition
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
WO2007099396A2 (en) * 2005-06-07 2007-09-07 Foamix Ltd. Antibiotic kit and composition and uses thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5429815A (en) * 1994-04-11 1995-07-04 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Stable single-phase self-foaming cleanser
US5783202A (en) * 1995-03-14 1998-07-21 Soltec Research Pty. Ltd. Pediculicidal mousse composition for killing head lice
US20030053961A1 (en) * 2001-07-13 2003-03-20 Eccard Wayne Ellis Mousse forming compositions comprising quaternary ammonium agents
EP1287813A1 (en) * 2001-08-28 2003-03-05 Coty Inc. Antiperspirant deodorant emulsion
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
EP1428521A2 (en) * 2002-12-13 2004-06-16 Unilever Plc Antiperspirant or deodorant composition
WO2007099396A2 (en) * 2005-06-07 2007-09-07 Foamix Ltd. Antibiotic kit and composition and uses thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8946276B2 (en) 2011-06-28 2015-02-03 Watson Laboratories, Inc. High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis
US9198858B2 (en) 2011-06-28 2015-12-01 Watson Pharmaceuticals, Inc. Methods of treating bacterial vaginosis with aqueous-based metronidazole gel formulations

Also Published As

Publication number Publication date
EP2029106A2 (en) 2009-03-04
WO2008038140A2 (en) 2008-04-03

Similar Documents

Publication Publication Date Title
WO2008038140A3 (en) Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof
IN2014DN07569A (en)
WO2007053675A3 (en) Blowing agents for forming foam comprising unsaturated fluorocarbons
EP2327753A3 (en) Aerosol propellants comprising unsaturated fluorocarbons
ATE514340T1 (en) FOAMING SOLUBLE COFFEE POWDER CONTAINING COMPRESSED GAS
WO2010040019A3 (en) Compositions for abrasion resistant foams and methods for making the same
MXPA05008479A (en) Film foaming hydroalcoholic foam.
WO2006023627A8 (en) Rapamycin polymorph ii and uses thereof
ZA200904540B (en) Pressurized can, such as an aerosol can
NO20035249D0 (en) Pressurized fluid tank, especially compressed gas tank for motor vehicles
WO2008067028A3 (en) High alcohol-content foams
PL1791438T3 (en) Powdered, cold-water soluble/dispersible, foamable composition
WO2006026657A3 (en) Method for reducing the freezing point of aminated aviation gasoline by the use of tertiaryamylphenylamine
WO2006136279A3 (en) Gas-forming agent for cement composition
IL162412A0 (en) Foamable compositions, processes of preparing sameand uses thereof
WO2009021036A3 (en) Flame retarded flexible polyurethane foams and flexible polyurethane foam formulations
MX2007007550A (en) Flame retardant expanded polystyrene foam compositions.
WO2009154374A3 (en) Permanent porous metal-organic frameworks having nbo-net topological structure comprising electrondonating azo group, and a gas container comprising the same
WO2010045435A3 (en) Salicylic acid composition
WO2007078679A3 (en) Practical, cost-effective synthesis of ubiquinones
WO2007038564A3 (en) Global transcription machinery engineering
PL354299A1 (en) Gas tank, particularly for liquid propane-butane gas
WO2006004613A3 (en) Guanylhydrazone salts, compositions, processes of making and methods of using
WO2007078771A3 (en) Fuel cell gas diffusion articles
RU2000121195A (en) FOAM FORMING FOAM GAS CONDENSATE

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2007848880

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: RU

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07848880

Country of ref document: EP

Kind code of ref document: A2